Recently, important advances have been made in ACC; a signature t(6;9)(q22–23; p23–24) chromosomal translocation resulting in a MYB–NFIB fusion gene was identified, and the fusion oncoprotein activates the transcription of MYB targets that are important for oncogenic transformation. Here, NFIB is linked to adrenal cortex carcinoma.